Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease
- 22 March 2023
- journal article
- research article
- Published by Elsevier in Ageing Research Reviews
- Vol. 87, 101915
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Pharmaceutical Education and Research, Raebareli
This publication has 105 references indexed in Scilit:
- Identification of Novel microRNAs in Post-Transcriptional Control of Nrf2 Expression and Redox Homeostasis in Neuronal, SH-SY5Y CellsPLOS ONE, 2012
- Critical role for calcium mobilization in activation of the NLRP3 inflammasomeProceedings of the National Academy of Sciences, 2012
- The atypical PKCs in inflammation: NF‐κB and beyondImmunological Reviews, 2012
- Mitochondrial Biology and Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic NeuronsThe American Journal of Pathology, 2011
- Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infectionNeurology, 2011
- Regulation of MyD88 Aggregation and the MyD88-dependent Signaling Pathway by Sequestosome 1 and Histone Deacetylase 6Journal of Biological Chemistry, 2010
- Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in miceMolecular Brain, 2010
- Mitochondrial dysfunction in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signalingProceedings of the National Academy of Sciences, 2007